The association of adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) with cardiovascular disease in subjects with antiphospholipid antibodies

Cardiovascular disease (CVD), including coronary artery disease and stroke/peripheral artery disease, is less commonly reported than venous thromboembolism in subjects with antiphospholipid antibodies (aPLs) and little is known about the association of CVD with adjusted Global AntiphosPholipid Syndrome Score (aGAPSS).

Source: Atherosclerosis - September 14, 2018 Category: Cardiology Authors: Matteo Nicola Dario Di Minno, Antonella Scalera, Antonella Tufano, Pasquale Ambrosino, Alessandra Bettiol, Elena Silvestri, Giacomo Emmi, Domenico Prisco Source Type: research